Literature DB >> 18190835

New frontiers in nanotechnology for cancer treatment.

Frank Alexis1, June-Wha Rhee, Jerome P Richie, Aleksandar F Radovic-Moreno, Robert Langer, Omid C Farokhzad.   

Abstract

Nanotechnology is a field of research at the crossroads of biology, chemistry, physics, engineering, and medicine. Design of multifunctional nanoparticles capable of targeting cancer cells, delivering and releasing drugs in a regulated manner, and detecting cancer cells with enormous specificity and sensitivity are just some examples of the potential application of nanotechnology to oncological diseases. In this review we discuss the recent advances of cancer nanotechnology with particular attention to nanoparticle systems that are in clinical practice or in various stages of development for cancer imaging and therapy.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18190835     DOI： 10.1016/j.urolonc.2007.03.017

Source DB:  PubMed          Journal:  Urol Oncol        ISSN： 1078-1439            Impact factor:   3.498


  62 in total

1.  A mixture theory model of fluid and solute transport in the microvasculature of normal and malignant tissues. I. Theory.

Authors:  M M Schuff; J P Gore; E A Nauman
Journal:  J Math Biol       Date:  2012-04-13       Impact factor: 2.259

2.  Raman microscopy for noninvasive imaging of pharmaceutical nanocarriers: intracellular distribution of cationic liposomes of different composition.

Authors:  T Chernenko; R R Sawant; M Miljkovic; L Quintero; M Diem; V Torchilin
Journal:  Mol Pharm       Date:  2012-03-15       Impact factor: 4.939

Review 3.  Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

Authors:  Xiaowei Dong; Russell J Mumper
Journal:  Nanomedicine (Lond)       Date:  2010-06       Impact factor: 5.307

Review 4.  Integrin α3β1 as a breast cancer target.

Authors:  Sita Subbaram; C Michael Dipersio
Journal:  Expert Opin Ther Targets       Date:  2011-08-13       Impact factor: 6.902

5.  Cellular senescence, ageing and disease.

Authors:  D G A Burton
Journal:  Age (Dordr)       Date:  2008-09-04

Review 6.  Strategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and market.

Authors:  Michele F Oliveira; Pedro P G Guimarães; Alinne D M Gomes; Diego Suárez; Rubén D Sinisterra
Journal:  J Chem Biol       Date:  2012-11-30

7.  Hexanoyl-Chitosan-PEG Copolymer Coated Iron Oxide Nanoparticles for Hydrophobic Drug Delivery.

Authors:  Meng-Hsuan Hsiao; Qingxin Mu; Zachary R Stephen; Chen Fang; Miqin Zhang
Journal:  ACS Macro Lett       Date:  2015-03-23       Impact factor: 6.903

Review 8.  Prospects of nano-material in breast cancer management.

Authors:  A K Singh; A Pandey; M Tewari; R Kumar; A Sharma; H P Pandey; H S Shukla
Journal:  Pathol Oncol Res       Date:  2013-02-23       Impact factor: 3.201

9.  Site-specific, thiol-mediated conjugation of fluorescent probes to cysteine-modified diabodies targeting CD20 or HER2.

Authors:  Shannon J Sirk; Tove Olafsen; Bhaswati Barat; Karl B Bauer; Anna M Wu
Journal:  Bioconjug Chem       Date:  2008-12       Impact factor: 4.774

Review 10.  Factors affecting the clearance and biodistribution of polymeric nanoparticles.

Authors:  Frank Alexis; Eric Pridgen; Linda K Molnar; Omid C Farokhzad
Journal:  Mol Pharm       Date:  2008-08-04       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.